Seriant (formerly MHICC)
Key Highlights
- Seriant has a rich history of 25 years in the pharmaceutical and biotech industries, with a strong foundation in cardiology research.
- The company offers a wide range of services including precision medicine, decentralized clinical trials, and medical & scientific writing.
- Seriant operates internationally, covering all clinical trial phases and a broad range of therapeutic areas.
- The company's commitment to excellence and dedication to transforming patient lives remain unwavering.
- Seriant continues to build upon its strong foundation in cardiology research, into new and exciting innovations and technologies, including precision medicine.
About Seriant (formerly MHICC)
Seriant (formerly MHICC) is a full-service Contract Research Organization (CRO) that has been serving the pharmaceutical and biotech industries, along with academia, for the past 25 years. Based in Montreal, Seriant operates internationally, covering all clinical trial phases and a broad range of therapeutic areas. The company has a rich history of bringing innovative therapies to life, creating meaningful impact for people all over the world. While the name has changed, Seriant continues to build upon its strong foundation in cardiology research, into new and exciting innovations and technologies, including precision medicine.
The company offers a wide range of services including precision medicine, decentralized clinical trials, project management, clinical operations & monitoring, biostatistics & programming, data management, regulatory affairs, medical & safety oversight, pharmacovigilance, medical & scientific writing, quality assurance, biobank, pharmacogenomics, and medical devices & wearables. These services are designed to support the development of innovative therapies and bring meaningful impact to patients worldwide.
Seriant's commitment to excellence and dedication to transforming patient lives remain unwavering. The company continues to build upon its strong foundation in cardiology research, into new and exciting innovations and technologies, including precision medicine. For more information, visit www.seriant.org or contact contact@seriant.org.
Why Contact Seriant (formerly MHICC)?
B2B professionals would contact Seriant for its extensive experience in the pharmaceutical and biotech industries, its wide range of services, and its commitment to excellence and innovation.
Who Should Contact Seriant (formerly MHICC) for Business?
Sales teams selling clinical trial services, recruiters seeking roles in the pharmaceutical and biotech industries, and partners offering precision medicine and decentralized clinical trials.
Categories
- Clinical Trials
- Pharmaceutical Research
- Biotechnology Services
- Precision Medicine
- Decentralized Clinical Trials
- Project Management
- Clinical Operations
- Biostatistics
- Data Management
- Regulatory Affairs
More Pharmaceutical Research Companies
Frequently Asked Questions
- How many employees does Seriant (formerly MHICC) have?
- Seriant (formerly MHICC) has approximately 71 employees.
- Where is Seriant (formerly MHICC) headquartered?
- Montreal, Quebec, Canada
- What industry is Seriant (formerly MHICC) in?
- Seriant (formerly MHICC) operates in Pharmaceutical Research, Biotechnology Services, Clinical Trial Management.
- When was Seriant (formerly MHICC) founded?
- Seriant (formerly MHICC) was founded in 2001.
- Is Seriant (formerly MHICC) still active?
- Yes, Seriant (formerly MHICC) was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to Seriant (formerly MHICC)?
- Research Seriant (formerly MHICC)'s priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to Seriant (formerly MHICC)?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with Seriant (formerly MHICC)